市場調査レポート

商品コード

1125951

世界のヒトインスリン薬市場：考察と予測 (2028年まで)

Global Human Insulin Drugs Market Insights, Forecast to 2028

出版日: 2022年09月16日 | 発行: QYResearch

| ページ情報: 英文 121 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 768,124円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,152,186円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,536,248円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートは、ヒトインスリン薬 (Human Insulin Drugs) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

ヒトインスリン薬の製品概要
市場：タイプ別
- 世界のヒトインスリン薬の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
- Basal or Long-acting Insulins
- Bolus or Fast-acting Insulins
- Traditional Human Insulins
- Combination Insulins
- Biosimilar Insulins
市場：アプリケーション別
- 世界のヒトインスリン薬の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
- Hospital
- Household
調査目的
対象期間

第2章レポート概要

世界のヒトインスリン薬の販売推定および予測 2017-2028
世界のヒトインスリン薬の収益推定および予測 2017-2028
世界のヒトインスリン薬の収益：地域別: 2017 VS 2021 VS 2028
世界のヒトインスリン薬の販売：地域別
- 世界のヒトインスリン薬の販売：地域別 (2017-2022)
- 世界の販売ヒトインスリン薬：地域別 (2023-2028)
世界のヒトインスリン薬の収益：地域別
- 世界のヒトインスリン薬の収益：地域別 (2017-2022)
- 世界のヒトインスリン薬の収益：地域別 (2023-2028)
北米
欧州
アジア太平洋地域
ラテンアメリカ
中東・アフリカ

第3章競合：メーカー別

世界のヒトインスリン薬の販売：メーカー別
- 世界のヒトインスリン薬の上位メーカー：販売別 (2017-2022)
- 世界のヒトインスリン薬の販売市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5メーカー：ヒトインスリン薬2021
世界のヒトインスリン薬の収益：メーカー別
- 世界のヒトインスリン薬の収益：メーカー別 (2017-2022)
- 世界のヒトインスリン薬の収益市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5企業：ヒトインスリン薬の収益 2021
世界のヒトインスリン薬の販売価格：メーカー別 (2017-2022)
競合情勢の分析
- メーカーの市場集中度 (CR5 and HHI)
- 世界のヒトインスリン薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
- 世界のヒトインスリン薬のメーカーの地理的分布
M&A, 拡張計画

第4章市場規模：タイプ別

世界のヒトインスリン薬の販売：タイプ別
- 世界のヒトインスリン薬の販売実績：タイプ別 (2017-2022)
- 世界のヒトインスリン薬の販売予測：タイプ別 (2023-2028)
- 世界のヒトインスリン薬の販売市場シェア：タイプ別 (2017-2028)
世界のヒトインスリン薬の収益：タイプ別
- 世界のヒトインスリン薬の収益実績：タイプ別 (2017-2022)
- 世界のヒトインスリン薬の収益予測：タイプ別 (2023-2028)
- 世界のヒトインスリン薬の収益市場シェア：タイプ別 (2017-2028)
世界のヒトインスリン薬の価格：タイプ別
- 世界のヒトインスリン薬の価格：タイプ別 (2017-2022)
- 世界のヒトインスリン薬の価格予測：タイプ別 (2023-2028)

第5章市場規模：アプリケーション別

世界のヒトインスリン薬の販売：アプリケーション別
- 世界のヒトインスリン薬の販売実績：アプリケーション別 (2017-2022)
- 世界のヒトインスリン薬の販売予測：アプリケーション別 (2023-2028)
- 世界のヒトインスリン薬の販売市場シェア：アプリケーション別 (2017-2028)
世界のヒトインスリン薬の収益：アプリケーション別
- 世界のヒトインスリン薬の収益実績：アプリケーション別 (2017-2022)
- 世界のヒトインスリン薬の収益予測：アプリケーション別 (2023-2028)
- 世界のヒトインスリン薬の収益市場シェア：アプリケーション別 (2017-2028)
世界のヒトインスリン薬の価格：アプリケーション別
- 世界のヒトインスリン薬の価格：アプリケーション別 (2017-2022)
- 世界のヒトインスリン薬の価格予測：アプリケーション別 (2023-2028)

第6章北米

北米のヒトインスリン薬市場規模：タイプ別
- 北米のヒトインスリン薬の販売：タイプ別 (2017-2028)
- 北米のヒトインスリン薬の収益：タイプ別 (2017-2028)
北米のヒトインスリン薬市場規模：アプリケーション別
- 北米のヒトインスリン薬の販売：アプリケーション別 (2017-2028)
- 北米のヒトインスリン薬の収益：アプリケーション別 (2017-2028)
北米のヒトインスリン薬市場規模：国別
- 北米のヒトインスリン薬の販売：国別 (2017-2028)
- 北米のヒトインスリン薬の収益：国別 (2017-2028)
- 米国
- カナダ

第7章欧州

欧州のヒトインスリン薬市場規模：タイプ別
- 欧州のヒトインスリン薬の販売：タイプ別 (2017-2028)
- 欧州のヒトインスリン薬の収益：タイプ別 (2017-2028)
欧州のヒトインスリン薬市場規模：アプリケーション別
- 欧州のヒトインスリン薬の販売：アプリケーション別 (2017-2028)
- 欧州のヒトインスリン薬の収益：アプリケーション別 (2017-2028)
欧州のヒトインスリン薬市場規模：国別
- 欧州のヒトインスリン薬の販売：国別 (2017-2028)
- 欧州のヒトインスリン薬の収益：国別 (2017-2028)
- ドイツ
- フランス
- 英国
- イタリア
- ロシア

第8章アジア太平洋

アジア太平洋のヒトインスリン薬市場規模：タイプ別
- アジア太平洋のヒトインスリン薬の販売：タイプ別 (2017-2028)
- アジア太平洋のヒトインスリン薬の収益：タイプ別 (2017-2028)
アジア太平洋のヒトインスリン薬市場規模：アプリケーション別
- アジア太平洋のヒトインスリン薬の販売：アプリケーション別 (2017-2028)
- アジア太平洋のヒトインスリン薬の収益：アプリケーション別 (2017-2028)
アジア太平洋のヒトインスリン薬市場規模：地域別
- アジア太平洋のヒトインスリン薬の販売：地域別 (2017-2028)
- アジア太平洋のヒトインスリン薬の収益：地域別 (2017-2028)
- 中国
- 日本
- 韓国
- インド
- オーストラリア
- 台湾
- インドネシア
- タイ
- マレーシア

第9章ラテンアメリカ

ラテンアメリカのヒトインスリン薬市場規模：タイプ別
- ラテンアメリカのヒトインスリン薬の販売：タイプ別 (2017-2028)
- ラテンアメリカのヒトインスリン薬の収益：タイプ別 (2017-2028)
ラテンアメリカのヒトインスリン薬市場規模：アプリケーション別
- ラテンアメリカのヒトインスリン薬の販売：アプリケーション別 (2017-2028)
- ラテンアメリカのヒトインスリン薬の収益：アプリケーション別 (2017-2028)
ラテンアメリカのヒトインスリン薬市場規模：国別
- ラテンアメリカのヒトインスリン薬の販売：国別 (2017-2028)
- ラテンアメリカのヒトインスリン薬の収益：国別 (2017-2028)
- メキシコ
- ブラジル
- アルゼンチン
- コロンビア

第10章中東・アフリカ

中東・アフリカのヒトインスリン薬市場規模：タイプ別
- 中東・アフリカのヒトインスリン薬の販売：タイプ別 (2017-2028)
- 中東・アフリカのヒトインスリン薬の収益：タイプ別 (2017-2028)
中東・アフリカのヒトインスリン薬市場規模：アプリケーション別
- 中東・アフリカのヒトインスリン薬の販売：アプリケーション別 (2017-2028)
- 中東・アフリカのヒトインスリン薬の収益：アプリケーション別 (2017-2028)
中東・アフリカのヒトインスリン薬市場規模：国別
- 中東・アフリカのヒトインスリン薬の販売：国別 (2017-2028)
- 中東・アフリカのヒトインスリン薬の収益：国別 (2017-2028)
- トルコ
- サウジアラビア

第11章企業プロファイル

Novo Nordisk
Sanofi
Eli Lilly
Biocon
Pfizer
Wockhardt
Julphar
Exir
Sedico

第12章業界チェーンと販売チャネルの分析

ヒトインスリン薬業界チェーン分析
ヒトインスリン薬主要原材料分析
- 主要原材料分析
- 原材料の主要サプライヤー
ヒトインスリン薬生産形態とプロセス
ヒトインスリン薬販売およびマーケティング
- ヒトインスリン薬販売チャネル
- ヒトインスリン薬卸業者
ヒトインスリン薬顧客

第13章市場の促進要因, 機会, 課題とリスク要因の分析

ヒトインスリン薬業界動向
ヒトインスリン薬市場の促進要因
ヒトインスリン薬市場の課題
ヒトインスリン薬市場の抑制要因

第14章世界のヒトインスリン薬の主な市場調査結果

第15章付録

図表

Table 1. Global Human Insulin Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Basal or Long-acting Insulins
Table 3. Major Manufacturers of Bolus or Fast-acting Insulins
Table 4. Major Manufacturers of Traditional Human Insulins
Table 5. Major Manufacturers of Combination Insulins
Table 6. Major Manufacturers of Biosimilar Insulins
Table 7. Global Human Insulin Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Human Insulin Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Human Insulin Drugs Sales by Region (2017-2022) & (K Units)
Table 10. Global Human Insulin Drugs Sales Market Share by Region (2017-2022)
Table 11. Global Human Insulin Drugs Sales by Region (2023-2028) & (K Units)
Table 12. Global Human Insulin Drugs Sales Market Share by Region (2023-2028)
Table 13. Global Human Insulin Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Human Insulin Drugs Revenue Market Share by Region (2017-2022)
Table 15. Global Human Insulin Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Human Insulin Drugs Revenue Market Share by Region (2023-2028)
Table 17. Global Human Insulin Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Human Insulin Drugs Sales Share by Manufacturers (2017-2022)
Table 19. Global Human Insulin Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Human Insulin Drugs Revenue Share by Manufacturers (2017-2022)
Table 21. Human Insulin Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Human Insulin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Human Insulin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Drugs as of 2021)
Table 24. Human Insulin Drugs Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Human Insulin Drugs Product Offered
Table 26. Date of Manufacturers Enter into Human Insulin Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Human Insulin Drugs Sales by Type (2017-2022) & (K Units)
Table 29. Global Human Insulin Drugs Sales by Type (2023-2028) & (K Units)
Table 30. Global Human Insulin Drugs Sales Share by Type (2017-2022)
Table 31. Global Human Insulin Drugs Sales Share by Type (2023-2028)
Table 32. Global Human Insulin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Human Insulin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Human Insulin Drugs Revenue Share by Type (2017-2022)
Table 35. Global Human Insulin Drugs Revenue Share by Type (2023-2028)
Table 36. Human Insulin Drugs Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Human Insulin Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Human Insulin Drugs Sales by Application (2017-2022) & (K Units)
Table 39. Global Human Insulin Drugs Sales by Application (2023-2028) & (K Units)
Table 40. Global Human Insulin Drugs Sales Share by Application (2017-2022)
Table 41. Global Human Insulin Drugs Sales Share by Application (2023-2028)
Table 42. Global Human Insulin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Human Insulin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Human Insulin Drugs Revenue Share by Application (2017-2022)
Table 45. Global Human Insulin Drugs Revenue Share by Application (2023-2028)
Table 46. Human Insulin Drugs Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Human Insulin Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Human Insulin Drugs Sales by Type (2017-2022) & (K Units)
Table 49. North America Human Insulin Drugs Sales by Type (2023-2028) & (K Units)
Table 50. North America Human Insulin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Human Insulin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Human Insulin Drugs Sales by Application (2017-2022) & (K Units)
Table 53. North America Human Insulin Drugs Sales by Application (2023-2028) & (K Units)
Table 54. North America Human Insulin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Human Insulin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Human Insulin Drugs Sales by Country (2017-2022) & (K Units)
Table 57. North America Human Insulin Drugs Sales by Country (2023-2028) & (K Units)
Table 58. North America Human Insulin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Human Insulin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Human Insulin Drugs Sales by Type (2017-2022) & (K Units)
Table 61. Europe Human Insulin Drugs Sales by Type (2023-2028) & (K Units)
Table 62. Europe Human Insulin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Human Insulin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Human Insulin Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Europe Human Insulin Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Europe Human Insulin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Human Insulin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Human Insulin Drugs Sales by Country (2017-2022) & (K Units)
Table 69. Europe Human Insulin Drugs Sales by Country (2023-2028) & (K Units)
Table 70. Europe Human Insulin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Human Insulin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Human Insulin Drugs Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Human Insulin Drugs Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Human Insulin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Human Insulin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Human Insulin Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Human Insulin Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Human Insulin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Human Insulin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Human Insulin Drugs Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Human Insulin Drugs Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Human Insulin Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Human Insulin Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Human Insulin Drugs Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Human Insulin Drugs Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Human Insulin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Human Insulin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Human Insulin Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Human Insulin Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Human Insulin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Human Insulin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Human Insulin Drugs Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Human Insulin Drugs Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Human Insulin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Human Insulin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Human Insulin Drugs Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Human Insulin Drugs Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Human Insulin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Human Insulin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Human Insulin Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Human Insulin Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Human Insulin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Human Insulin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Human Insulin Drugs Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Human Insulin Drugs Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Human Insulin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Human Insulin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 108. Novo Nordisk Corporation Information
Table 109. Novo Nordisk Description and Major Businesses
Table 110. Novo Nordisk Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. Novo Nordisk Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Novo Nordisk Recent Developments
Table 113. Sanofi Corporation Information
Table 114. Sanofi Description and Major Businesses
Table 115. Sanofi Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Sanofi Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Sanofi Recent Developments
Table 118. Eli Lilly Corporation Information
Table 119. Eli Lilly Description and Major Businesses
Table 120. Eli Lilly Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Eli Lilly Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Eli Lilly Recent Developments
Table 123. Biocon Corporation Information
Table 124. Biocon Description and Major Businesses
Table 125. Biocon Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Biocon Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Biocon Recent Developments
Table 128. Pfizer Corporation Information
Table 129. Pfizer Description and Major Businesses
Table 130. Pfizer Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Pfizer Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Pfizer Recent Developments
Table 133. Wockhardt Corporation Information
Table 134. Wockhardt Description and Major Businesses
Table 135. Wockhardt Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. Wockhardt Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Wockhardt Recent Developments
Table 138. Julphar Corporation Information
Table 139. Julphar Description and Major Businesses
Table 140. Julphar Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Julphar Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Julphar Recent Developments
Table 143. Exir Corporation Information
Table 144. Exir Description and Major Businesses
Table 145. Exir Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Exir Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Exir Recent Developments
Table 148. Sedico Corporation Information
Table 149. Sedico Description and Major Businesses
Table 150. Sedico Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. Sedico Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Sedico Recent Developments
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Human Insulin Drugs Distributors List
Table 156. Human Insulin Drugs Customers List
Table 157. Human Insulin Drugs Market Trends
Table 158. Human Insulin Drugs Market Drivers
Table 159. Human Insulin Drugs Market Challenges
Table 160. Human Insulin Drugs Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Insulin Drugs Product Picture
Figure 3. Global Human Insulin Drugs Market Share by Type in 2021 & 2028
Figure 3. Basal or Long-acting Insulins Product Picture
Figure 4. Bolus or Fast-acting Insulins Product Picture
Figure 5. Traditional Human Insulins Product Picture
Figure 6. Combination Insulins Product Picture
Figure 7. Biosimilar Insulins Product Picture
Figure 8. Global Human Insulin Drugs Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Household
Figure 11. Human Insulin Drugs Report Years Considered
Figure 12. Global Human Insulin Drugs Sales 2017-2028 (K Units)
Figure 13. Global Human Insulin Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Human Insulin Drugs Revenue 2017-2028 (US$ Million)
Figure 15. Global Human Insulin Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Human Insulin Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Human Insulin Drugs Sales Market Share by Region (2023-2028)
Figure 18. North America Human Insulin Drugs Sales YoY (2017-2028) & (K Units)
Figure 19. North America Human Insulin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Human Insulin Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Human Insulin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Human Insulin Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Human Insulin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Human Insulin Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Human Insulin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Human Insulin Drugs Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Human Insulin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Human Insulin Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Human Insulin Drugs in the World: Market Share by Human Insulin Drugs Revenue in 2021
Figure 30. Global Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Human Insulin Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Human Insulin Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Human Insulin Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Human Insulin Drugs Revenue Market Share by Application (2017-2028)
Figure 35. North America Human Insulin Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Human Insulin Drugs Revenue Market Share by Type (2017-2028)
Figure 37. North America Human Insulin Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Human Insulin Drugs Revenue Market Share by Application (2017-2028)
Figure 39. North America Human Insulin Drugs Sales Share by Country (2017-2028)
Figure 40. North America Human Insulin Drugs Revenue Share by Country (2017-2028)
Figure 41. United States Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Human Insulin Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Human Insulin Drugs Revenue Market Share by Type (2017-2028)
Figure 45. Europe Human Insulin Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Human Insulin Drugs Revenue Market Share by Application (2017-2028)
Figure 47. Europe Human Insulin Drugs Sales Share by Country (2017-2028)
Figure 48. Europe Human Insulin Drugs Revenue Share by Country (2017-2028)
Figure 49. Germany Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. France Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Human Insulin Drugs Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Human Insulin Drugs Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Human Insulin Drugs Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Human Insulin Drugs Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Human Insulin Drugs Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Human Insulin Drugs Revenue Share by Region (2017-2028)
Figure 60. China Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. India Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Human Insulin Drugs Sales Market Share by Type (2017-2028)
Figure 70. Latin America Human Insulin Drugs Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Human Insulin Drugs Sales Market Share by Application (2017-2028)
Figure 72. Latin America Human Insulin Drugs Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Human Insulin Drugs Sales Share by Country (2017-2028)
Figure 74. Latin America Human Insulin Drugs Revenue Share by Country (2017-2028)
Figure 75. Mexico Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Colombia Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Human Insulin Drugs Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Human Insulin Drugs Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Human Insulin Drugs Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Human Insulin Drugs Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Human Insulin Drugs Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Human Insulin Drugs Revenue Share by Country (2017-2028)
Figure 85. Turkey Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Human Insulin Drugs Revenue (2017-2028) & (US$ Million)
Figure 88. Human Insulin Drugs Value Chain
Figure 89. Human Insulin Drugs Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

This research report focuses on the Human Insulin Drugs Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

1 Study Coverage

1.1 Human Insulin Drugs Product Introduction
1.2 Market by Type
- 1.2.1 Global Human Insulin Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Basal or Long-acting Insulins
- 1.2.3 Bolus or Fast-acting Insulins
- 1.2.4 Traditional Human Insulins
- 1.2.5 Combination Insulins
- 1.2.6 Biosimilar Insulins
1.3 Market by Application
- 1.3.1 Global Human Insulin Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Hospital
- 1.3.3 Household
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary

2.1 Global Human Insulin Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Human Insulin Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Insulin Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Insulin Drugs Sales by Region
- 2.4.1 Global Human Insulin Drugs Sales by Region (2017-2022)
- 2.4.2 Global Sales Human Insulin Drugs by Region (2023-2028)
2.5 Global Human Insulin Drugs Revenue by Region
- 2.5.1 Global Human Insulin Drugs Revenue by Region (2017-2022)
- 2.5.2 Global Human Insulin Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Human Insulin Drugs Sales by Manufacturers
- 3.1.1 Global Top Human Insulin Drugs Manufacturers by Sales (2017-2022)
- 3.1.2 Global Human Insulin Drugs Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Insulin Drugs in 2021
3.2 Global Human Insulin Drugs Revenue by Manufacturers
- 3.2.1 Global Human Insulin Drugs Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Human Insulin Drugs Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Human Insulin Drugs Revenue in 2021
3.3 Global Human Insulin Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Human Insulin Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Human Insulin Drugs Sales by Type
- 4.1.1 Global Human Insulin Drugs Historical Sales by Type (2017-2022)
- 4.1.2 Global Human Insulin Drugs Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Human Insulin Drugs Sales Market Share by Type (2017-2028)
4.2 Global Human Insulin Drugs Revenue by Type
- 4.2.1 Global Human Insulin Drugs Historical Revenue by Type (2017-2022)
- 4.2.2 Global Human Insulin Drugs Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Human Insulin Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Human Insulin Drugs Price by Type
- 4.3.1 Global Human Insulin Drugs Price by Type (2017-2022)
- 4.3.2 Global Human Insulin Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Human Insulin Drugs Sales by Application
- 5.1.1 Global Human Insulin Drugs Historical Sales by Application (2017-2022)
- 5.1.2 Global Human Insulin Drugs Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Human Insulin Drugs Sales Market Share by Application (2017-2028)
5.2 Global Human Insulin Drugs Revenue by Application
- 5.2.1 Global Human Insulin Drugs Historical Revenue by Application (2017-2022)
- 5.2.2 Global Human Insulin Drugs Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Human Insulin Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Human Insulin Drugs Price by Application
- 5.3.1 Global Human Insulin Drugs Price by Application (2017-2022)
- 5.3.2 Global Human Insulin Drugs Price Forecast by Application (2023-2028)

6 North America

6.1 North America Human Insulin Drugs Market Size by Type
- 6.1.1 North America Human Insulin Drugs Sales by Type (2017-2028)
- 6.1.2 North America Human Insulin Drugs Revenue by Type (2017-2028)
6.2 North America Human Insulin Drugs Market Size by Application
- 6.2.1 North America Human Insulin Drugs Sales by Application (2017-2028)
- 6.2.2 North America Human Insulin Drugs Revenue by Application (2017-2028)
6.3 North America Human Insulin Drugs Market Size by Country
- 6.3.1 North America Human Insulin Drugs Sales by Country (2017-2028)
- 6.3.2 North America Human Insulin Drugs Revenue by Country (2017-2028)
- 6.3.3 United States
- 6.3.4 Canada

7 Europe

7.1 Europe Human Insulin Drugs Market Size by Type
- 7.1.1 Europe Human Insulin Drugs Sales by Type (2017-2028)
- 7.1.2 Europe Human Insulin Drugs Revenue by Type (2017-2028)
7.2 Europe Human Insulin Drugs Market Size by Application
- 7.2.1 Europe Human Insulin Drugs Sales by Application (2017-2028)
- 7.2.2 Europe Human Insulin Drugs Revenue by Application (2017-2028)
7.3 Europe Human Insulin Drugs Market Size by Country
- 7.3.1 Europe Human Insulin Drugs Sales by Country (2017-2028)
- 7.3.2 Europe Human Insulin Drugs Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Human Insulin Drugs Market Size by Type
- 8.1.1 Asia Pacific Human Insulin Drugs Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Human Insulin Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Human Insulin Drugs Market Size by Application
- 8.2.1 Asia Pacific Human Insulin Drugs Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Human Insulin Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Human Insulin Drugs Market Size by Region
- 8.3.1 Asia Pacific Human Insulin Drugs Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Human Insulin Drugs Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 China Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia

9 Latin America

9.1 Latin America Human Insulin Drugs Market Size by Type
- 9.1.1 Latin America Human Insulin Drugs Sales by Type (2017-2028)
- 9.1.2 Latin America Human Insulin Drugs Revenue by Type (2017-2028)
9.2 Latin America Human Insulin Drugs Market Size by Application
- 9.2.1 Latin America Human Insulin Drugs Sales by Application (2017-2028)
- 9.2.2 Latin America Human Insulin Drugs Revenue by Application (2017-2028)
9.3 Latin America Human Insulin Drugs Market Size by Country
- 9.3.1 Latin America Human Insulin Drugs Sales by Country (2017-2028)
- 9.3.2 Latin America Human Insulin Drugs Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina
- 9.3.6 Colombia

10 Middle East and Africa

10.1 Middle East and Africa Human Insulin Drugs Market Size by Type
- 10.1.1 Middle East and Africa Human Insulin Drugs Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Human Insulin Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Insulin Drugs Market Size by Application
- 10.2.1 Middle East and Africa Human Insulin Drugs Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Human Insulin Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Insulin Drugs Market Size by Country
- 10.3.1 Middle East and Africa Human Insulin Drugs Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Human Insulin Drugs Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia

11 Company Profiles

11.1 Novo Nordisk
- 11.1.1 Novo Nordisk Corporation Information
- 11.1.2 Novo Nordisk Overview
- 11.1.3 Novo Nordisk Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 Novo Nordisk Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi
- 11.2.1 Sanofi Corporation Information
- 11.2.2 Sanofi Overview
- 11.2.3 Sanofi Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 Sanofi Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Sanofi Recent Developments
11.3 Eli Lilly
- 11.3.1 Eli Lilly Corporation Information
- 11.3.2 Eli Lilly Overview
- 11.3.3 Eli Lilly Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 Eli Lilly Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Eli Lilly Recent Developments
11.4 Biocon
- 11.4.1 Biocon Corporation Information
- 11.4.2 Biocon Overview
- 11.4.3 Biocon Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 Biocon Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 Biocon Recent Developments
11.5 Pfizer
- 11.5.1 Pfizer Corporation Information
- 11.5.2 Pfizer Overview
- 11.5.3 Pfizer Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Pfizer Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Pfizer Recent Developments
11.6 Wockhardt
- 11.6.1 Wockhardt Corporation Information
- 11.6.2 Wockhardt Overview
- 11.6.3 Wockhardt Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 Wockhardt Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 Wockhardt Recent Developments
11.7 Julphar
- 11.7.1 Julphar Corporation Information
- 11.7.2 Julphar Overview
- 11.7.3 Julphar Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 Julphar Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Julphar Recent Developments
11.8 Exir
- 11.8.1 Exir Corporation Information
- 11.8.2 Exir Overview
- 11.8.3 Exir Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 Exir Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 Exir Recent Developments
11.9 Sedico
- 11.9.1 Sedico Corporation Information
- 11.9.2 Sedico Overview
- 11.9.3 Sedico Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 Sedico Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 Sedico Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Human Insulin Drugs Industry Chain Analysis
12.2 Human Insulin Drugs Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
12.3 Human Insulin Drugs Production Mode & Process
12.4 Human Insulin Drugs Sales and Marketing
- 12.4.1 Human Insulin Drugs Sales Channels
- 12.4.2 Human Insulin Drugs Distributors
12.5 Human Insulin Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Human Insulin Drugs Industry Trends
13.2 Human Insulin Drugs Market Drivers
13.3 Human Insulin Drugs Market Challenges
13.4 Human Insulin Drugs Market Restraints

14 Key Findings in The Global Human Insulin Drugs Study

15 Appendix

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

世界のヒトインスリン薬市場：考察と予測 (2028年まで)

Global Human Insulin Drugs Market Insights, Forecast to 2028

目次

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界のヒトインスリン薬の主な市場調査結果

第15章付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Human Insulin Drugs Study

15 Appendix

世界のヒトインスリン薬市場：考察と予測 (2028年まで)

Global Human Insulin Drugs Market Insights, Forecast to 2028

目次

第1章 調査対象

第2章 レポート概要

第3章 競合：メーカー別

第4章 市場規模：タイプ別

第5章 市場規模：アプリケーション別

第6章 北米

第7章 欧州

第8章 アジア太平洋

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 企業プロファイル

第12章 業界チェーンと販売チャネルの分析

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

第14章 世界のヒトインスリン薬の主な市場調査結果

第15章 付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Human Insulin Drugs Study

15 Appendix

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界のヒトインスリン薬の主な市場調査結果

第15章付録